Nanjing Seamild Big Health Technology Co., Ltd. announced that it will receive CNY 70,000,000 in its equity round of funding on August 31, 2020. The transaction will include participation from returning investor Guilin Seamild Foods Co., Ltd (SZSE:002956). On closing, the investor retains its 100% stake in the company. As part of the transaction, CNY 5,000,000 going into registered capital and CNY 65,000,000 going into capital reserve.The transaction has been approved by board of directors of the Guilin Seamild Foods Co., Ltd (SZSE:002956) in its third meeting of the second board of directors.